AIGEN Sciences provides an AI-driven drug discovery platform that accelerates the identification of lead drug candidates from years to just six months. By leveraging advanced natural language processing and proprietary LLMs (including BioBERT and Meerkat 7B), the platform enables users to interact with and analyze chemical structures in plain English, design and rank molecules, and optimize lead compounds efficiently. This tool is designed for biotech companies, pharmaceutical researchers, and drug discovery teams seeking to dramatically reduce R&D timelines.
Visit AIGEN Sciences's official website for product details and getting started.
Comprehensive API documentation and user guides for leveraging the AIGEN Sciences platform.
Insights and articles on AI in drug discovery and updates about AIGEN Sciences.
Information on subscription plans and pricing for the AIGEN Sciences platform.